V
EXAS

Veritable’s Exact Sciences EXAS Stock Holding History

Veritable’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,923
Closed -$204K – 929
2022
Q1 		$204K Buy
2,923
+228
+8% +$16.7K ﹤0.01% 859
2021
Q4 		$210K Sell
2,695
-77
-3% -$6.8K ﹤0.01% 869
2021
Q3 		$265K Sell
2,772
-1,497
-35% -$158K ﹤0.01% 740
2021
Q2 		$531K Buy
+4,269
New +$510K 0.01% 525

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Veritable's EXAS Position: Q2 2022 in Review

Veritable sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 2,923 shares — an estimated $204K sold.

Veritable first reported a position in EXAS in Q2 2021 and held it in 4 quarters. The position peaked at $531K in Q2 2021. 500 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Veritable reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Veritable sold 2,923 Exact Sciences shares in Q2 2022, an estimated $204K.
  • Veritable first reported a position in Exact Sciences in Q2 2021 and held it in 4 quarters.
  • Veritable's Exact Sciences position peaked at $531K in Q2 2021.
  • 500 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Veritable's 13F filing for Q2 2022, filed 15 Aug 2022.